Intranasal administration of an aronia extract and carrageenan nanocomposite for the prevention of influenza A H1N1 virus infection.

MLA

Lee, Jangsu, et al. “Intranasal Administration of an Aronia Extract and Carrageenan Nanocomposite for the Prevention of Influenza A H1N1 Virus Infection.” Journal of Pharmaceutical Investigation (2093-5552), vol. 52, no. 6, Nov. 2022, pp. 765–74. EBSCOhost, https://doi.org/10.1007/s40005-022-00591-x.

APA

Lee, J., Kim, K. S., & Na, K. (2022). Intranasal administration of an aronia extract and carrageenan nanocomposite for the prevention of influenza A H1N1 virus infection. Journal of Pharmaceutical Investigation (2093-5552), 52(6), 765–774. https://doi.org/10.1007/s40005-022-00591-x

Chicago

Lee, Jangsu, Kyoung Sub Kim, and Kun Na. 2022. “Intranasal Administration of an Aronia Extract and Carrageenan Nanocomposite for the Prevention of Influenza A H1N1 Virus Infection.” Journal of Pharmaceutical Investigation (2093-5552) 52 (6): 765–74. doi:10.1007/s40005-022-00591-x.